Key regulatory points for Epitalon Australia compliance: Epitalon is not approved by the Therapeutic Goods Administration (TGA) as a registered medicine for human or veterinary use It is classified strictly for laboratory and research purposes, not for human consumption Supply, import, and handling of research peptides fall under Australian regulatory oversight, and institutions should confirm current scheduling status directly through TGA resources before procurement Any research involving human subjects must comply with Research Ethics Committee approval and applicable Good Clinical Practice standards Marketing or supplying Epitalon with therapeutic claims, or implying suitability for human treatment, falls outside permitted research-use classifications Researchers and institutions should treat Epitalon strictly as a laboratory reagent, ensuring internal documentation, handling protocols, and communications consistently reflect its research-only status
Do not smoke or consume alcohol
AOD-9604 primarily works by enhancing lipolysis while inhibiting lipogenesis, leading to a direct reduction in fat accumulation
Here we discuss some common causes of hyperpigmentation
The main outcome measures were the proportion of patients achieving at least a 5% or 10% reduction in body weight and the mean change in body weight after 1 year
